tirzepatide thyroid cancer and Risk in Individuals with and without Diabetes: A Systematic Review and Meta-Analysis Black Box Warning of Tirzepatide
Description
With the weight-loss drug market surpassing $100 billion, legal and regulatory risks are intensifying
Mild increases in pancreatic enzyme levels were observed in both groups, with higher elevations in the dulaglutide group
Recent Findings Clinical trials have proven that the widely used GLP-1 analogues have pleotropic effects beyond those on weight and glucose metabolism and appear to confer favourable cardiovascular and renal outcomes
Women with T2DM have a similarly high risk for pregnancy complications as pregnant women with type 1 diabetes...
Experts say the study findings do not show that the GLP-1 obesity drug Zepbound causes adverse outcomes
Discover how semaglutide works to support weight loss and health improvement
